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Summary
With the advancement of human genome project, most of gene mapping and se-
quencing work has been completed. Thus, the next important work moves to
functional genomics. Among various methods developed for exploring gene expres-
sion, microarray technology has attracted more and more researchers’ attention
in the past several years. They used the microarry data to investigate expression
partterns of genes in tumors to classify them. Their studies have demonstrated
the potential utility of profiling gene expressions for cancer diagnosis. In gene
expression-based tumor classification systems, one of the important components is
gene selection. In this thesis, we will review some useful methods for gene selection
and tumor classification. We also propose a new method for this purpose.
This thesis consists of four chapters. In Chapter 1, we firstly introduce some bio-
logical fundamentals about microarray techniques. Then, we present some mathe-
matical and statistical knowledge needed in gene selection and classification at the
end of this chapter.
In Chapter 2, we discuss some classification methods which have been studied
extensively in the past. We limit ourselves to a binary class discriminant problem,
vi
Summary vii
that is, how to build a classifier from a given microarray data which contains two
distinct classes of samples, for instance, normal vs cancer or two different subtypes
of a cancer. Important methods of classification which can be applied in molecular
classification such as Fisher’s linear discriminant, Bayesian classification, support
vector machines (SVMs) and boosting method will be introduced in this chapter.
In Chapter 3, we present some useful gene selection methods published in re-
cent years, for example, prediction strength method (Golub et al, 1999), pre-filter
method (Jaeger et al, 2003), gene selection by mathematical programming, and a
very robust method called nonparametric scoring method (Park et al, 2001).
Finally, we will propose a new and simple gene selection method. Instead of inves-
tigating the detailed gene expression values themselves, we turn to study a reduced
form. Then, by projecting the reduced gene expression values onto an idealized ex-
pression vector, we analyze how a gene expresses different in two classes of samples
and select informative genes. With these genes selected by our approach, we ap-
ply Fisher’s linear discriminant and SVMs to classify tissues in colon cancer data,
and acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) data.
The results of classification show that our method is very useful and promising.
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Chapter 1
Primer to Molecular Biology and
Statistics
In this chapter, we introduce some basic concepts in molecular genetics. Then, we
will present the microarray techniques in Section 2. Finally, we will summarize
some necessary terminologies in statistics and mathematical programming which
are relevant to gene selection and tissue classification using microarray data.
1.1 Molecular Genetics
In nucleus of every cell, there is a genome which consists of tightly coiled threads
of deoxyribo nucleic acid (DNA) and associated protein molecules, organized into
structures called chromosomes (see [28]). DNA molecules encode all the informa-
tion necessary for building and maintaining life, from simple bacteria to remarkably
complex human beings. DNA molecule has a double-strand construction, and each
strand of DNA consists of repeating nucleotide units composed of a phosphate,
a sugar, and a base (A, C, G, T). The two ends of this molecule are chemically
different, i.e., the sequence has a directionality, as follows:
1
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A–>G–>T–>C–>C–>A–>A–>G–>C–>T–>T–> .
By convention, the end of the polynucleotide is marked with 5′ left and 3′ right
(this corresponds to the number of the OH groups of the sugar ring). And the
coding strand is at top. Two such strands are termed complementary, if one can
be obtained from the other by mutually exchanging A with T and C with G, and
changing the direction of the molecule to the opposite. For instance,
<–T<–C<–A<–G<–G<–T<–T<–C<–G<–A<–A
is complementary to the polynucleotide given above. The two complementary
strands are linked by hydrogen bonds formed between each A-T pair, and each
C-G pair. Although such interactions are individually weak, when two longer com-




C -G -A -T -T -G -C -A -A -C -G -A -T -G -C 3
′
| | | | | | | | | | | | | | |
3
′
G-C -T -A -A -C -G -T -T -G -C -T -A -C -G 5
′
The A-T and G-C pairs are called base-pairs (bp). The length of a DNA molecule is
usually measured in base-pairs. Two complementary polynucleotide chains form a
stable structure, which resembles a helix and is known as a the DNA double helix.
In a typical cell there are one or several long double stranded DNA molecules
organized as chromosomes. All organisms have genomes and they are believed to
encode almost all the hereditary information of the organism.
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Furthermore, there is a molecular machinery in cells, which keeps both DNA
strands intact and complementary. Namely, if one strand is damaged, it is re-
paired using the second as a template. Such machinery is important since DNA
damage (caused by environmental factors like radiation) can result in breaks in one
or both strands, or mispairing of the bases, which would disrupt the replication
of DNA. If damaged DNA is not repaired, the result can be cell death or tumors.
Changes in genomic DNA are known as mutations.
Each DNA molecule contains many genes. A gene is the functional and physical
unit of heredity passed from parent to offspring through mitosis. It is an ordered
sequence of nucleotides located in a particular position on a particular chromosome
and most genes contain the information for encoding a specific protein or RNA
molecule. It was estimated there are about thirty to forty thousands genes in
human. Actually, a gene is not a continuous part of DNA sequence, but consists
of exons and introns. Exons are the part of the gene that code for proteins and
they are interspersed with noncoding introns.
Like DNA, RNA is another molecule constructed from nucleotides. But instead of
the pyrimidine thymine (T), it has an alternative uracil (U), which is not found in
DNA. Because of this minor difference, RNA does not form a double helix, instead
usually they are single stranded. RNA plays the key role in the synthesis of protein.
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1.2 Microarray Techniques
Microarray technology makes use of the sequence resources created by the genome
projects and other sequencing efforts to answer the question: what genes are ex-
pressed in a particular cell type of an organism, at a particular time, under particu-
lar conditions. For instance, they allow comparison of gene expression between nor-
mal and diseased (e.g., cancerous) cells. (see, http://www.ebi.ac.uk/microarray/biology-
intro.htm#Genomes).
When two complementary single-stranded nucleic acid sequences meet, they tend
to bind together. Microarray technology exploits such complementarity and mutual
selectivity between them. A microarray is typically a glass (or some other material)
slide, on to which many fragments of gene sequences in the genome are attached at
spots. A slide may contain tens of thousands of spots. These sequences are either
printed on the microarrays by a robot, or synthesized by photo-lithography or by
ink-jet printing. We call fragments of gene sequence printed on the array probes.
Usually for yeast and prokaryote, the DNA probes are PCR products, see Box 1.1
below for detailed explanation of PCR.
Polymerase Chain Reaction (PCR) is a process based
on a specialized polymerase enzyme, which can synthesize a
complementary strand to a given DNA strand in a mixture
containing the 4 DNA bases and 2 DNA fragments (primers,
each about 20 bases long) flanking the target sequence. The
mixture is heated to separate the stands of double-stranded
DNA containing the target sequence and then cooled to allow:
(i) the primers to find and bind to their complementary
sequences on the separated strands; and (ii) the polymerase
to extend the primers into new complementary strands. Re-
peat heating and cooling cycles multiply the target DNA
exponentially, since each new double stand separates to
become two templates for further synthesis. In about 1 hour,
20 PCR cycles can amplify the target by a millionfold.
Box 1.1 Polymerase Chain Reaction (PCR)
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However, this approach would not work for the higher eukaryotic organisms such
as mouse, and human as these genomes contain many more introns. So, the re-
searchers sometimes turned to Expressed Sequence Tags (ESTs). Recently scien-
tists have exploited a new oligonucleotides based microarray. By virtue of this
techniques they can create a probe directly from a genome sequence ([26]).
For gene expression studies, we try to reduce the redundancy of a clone so as to
cover the broadest possible set of genes. In [15], to discover different gene expres-
sion level between ALL and AML, Golub et al used oligonucleotide microarrays
containing probes for 6817 human genes.
To profile gene expression in a given cell population, the total mRNA from the
cells of test and reference samples is extracted and reverse-transcribed to single
stranded cDNA by enzyme. Then these cDNAs are labelled with two different
fluorescent labels, for example, a green dye for cells of test samples and a red dye
for cells of reference. Then, these labelled targets hybridize to their complementary
sequences in the spots.
The dyes enable the amount of sample bound to a spot to be measured by the
level of fluorescence emitted when it is excited by a laser. If the RNA from the
test samples is in abundance, the spot will be green, if the RNA from the reference
samples is in abundance, it will be red. If both are equal, the spot will be yellow,
while if neither are present it will not fluoresce and appear black. Thus, from the
fluorescence intensities and colours for each spot, the relative expression levels of
the genes in both samples can be estimated. See Figure 1.1 ([12]) for more details.
By microarray techniques the scientists can profile expression patterns of thousands
of genes in a 1 cm2 slide, they have applied this promising technology in various
areas, such as exploring the differential gene expression, new genes discovery, large
scale sequencing and single nucleotide polymorphisms (SNPs) detection. Recently,
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Figure 1.1: cDNA microarray schema.
Templates for genes of interest are obtained and are printed on slides. Total RNA from both the test and reference
sample is reverse-transcribed to cDNA and labelled with fluorescent labels. The fluorescent targets hybridize to
the clones on the array. Laser excitation yields the emission of fluorescence which is measured using a scanner.
Images from the scanner are dealed with software and the final gene expression matrix is obtained.
it has been suggested that monitoring gene expression by microarray could pro-
vide a tool for cancer classification. Many researchers have studied the expression
patterns of the genes in colon, breast, and other tumors, and developed some sys-
tematic approaches ([15, 1]). Their studies have demonstrated the potential utility
of expression profiling for classifying tumors. In addition, scientists can identify
what kind of drugs are effective for a certain type of patients by screening the DNA
for genetic modification.
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1.3 Some Preliminary Knowledge
In this section, we summarize some important notions and concepts, such as Pear-
son’s correlation, P -values and KKT conditions, which will be used in the rest of
this thesis.
1.3.1 Pearson’s Correlation
The correlation between two vector variables reflects the degree to which the vari-
ables are related. Of the many relationships, the investigation of a linear relation-
ship is quite prevalent in the literature. The most common measure of correlation
is the Pearson Correlation [10]. Pearson correlation measures the strength and
direction of a linear relationship between two variables. It ranges from +1 to -1.
A correlation of ± 1 means that the variables are linearly related. A correlation of
0 means that they are not linearly related.
To define Pearson’s correlation, let us make some notations. Given two vector
variables (or samples) X = (x1, x2, · · · , xN) and Y = (y1, y2, · · · , yN), let Xvar,
Yvar and XYcov denote the variances of X, Y and covariance of them, respectively.
The Pearson correlation rXY is defined as the ratio of covariance over the product
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rXY =
∑N
i=1(xi − X¯)(yi − Y¯ )/(N − 1)√∑N
i=1(xi − X¯)2/(N − 1)
√∑N
i=1(yi − Y¯ )2/(N − 1)
, (1.2)
where X¯ and Y¯ denote the sample mean values of X and Y , respectively.
1.3.2 P -values
When we consider statistical problems involving a parameter θ whoes value is
unkown but must be decided whether to lie in a set A or the complement of A, Ac.
We shall let H0 denote the hypothesis that θ ∈ A, which is called null hypothesis;
and letH1 denote the hypothesis that θ ∈ Ac, which is called alternative hypothesis.
We must decide whether to accept the hypothesis H0 or to accept the hypothesis
H1. This procedure is called a test procedure. Suppose that before we decide
which hypothesis to accept, we can have some observations of random samples
X1, · · · , Xn, which are drawn from a distribution providing us with information
about the value of θ. Let S be the set of all possible outcomes ofX = (X1, · · · , Xn),
we can specify a test procedure by partitioning S into two subsets. One subset
contains the values of X for which we will accept H0, and the other subset which
we will accept H1. The subset for which H0 will be rejected is called rejection
region. The null hypothesis will be rejected if we observe X falling in the rejection
region.
A general way to report the result of a hypothesis testing analysis is to simply
say whether the null hypothesis is rejected at a specified level of significance. For
example, an investigator might state that H0 is rejected at level of significance 0.05,
or that use of a level 0.01 test resulted in not rejecting H0. This type of statement
is somewhat inadequate because it says nothing about whether the computed value
of the test statistic just barely fell into the rejection region or whether it exceeded
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the critical value by a large amount. A related difficulty is that such a report
imposes the specified significance level on other decision makers. In many decision
situations individuals may have different views concerning the consequences of a
type I or type II error (A type I error consists of rejecting the null hypothesis H0
when it is true. A type II error involves not rejecting H0 when H0 is false.). Each
individual would then want to select his own significance level – some selecting
α = 0.05, or 0.01 and so on, and reach a conclusion accordingly. This could result
in some individuals rejecting H0 while others conclude that the data does not show
a strong enough contradiction of H0 to justify its rejection.
A P -value [10] conveys more information about the strength of evidence against
H0 and allows an individual decision maker to draw a conclusion at any specified
level α.
The P -value (or observed significance level) is the smallest level of significance at
which H0 would be rejected when a specified test procedure is used on a given data
set. Once the P -value has been determined, the conclusion at any particular level
α results from comparing the P -value to α:
a). if P -value ≤ α, then reject H0 at level α.
b). if P -value > α, then do not reject H0 at level α.
In the following, we will present an example, which shows how to apply the P -value
for a z test. A z test is a test statistic whose distribution is approximately standard
normal when H0 is true [10]. For upper-tailed test and at significance level α, the
null hypothesis is rejected if z (the computed value of the test statistic Z) is not
less than zα where zα is the αth quantile of the standard normal distribution.
Since the P -value is the smallest α for which H0 is rejected, it exactly takes the
value of α satisfying z = zα. Hence, in this case P -value=1−Φ(z), where Φ(z) is the
standard normal distribution function, while for a lower-tailed test P -value=Φ(z).
When the test is a two-tailed test the P -value takes the value of 2[1−Φ(|z|)]. For
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examples in using P -value in hypothesis testing, see page 340 - 344 in [10].
1.3.3 Karush-Kuhn-Tucker Conditions
Let X be a nonempty open set in Rn, and let f : Rn → R, gi : Rn → R for
i = 1, 2, · · · ,m, and hi : Rn → R for i = 1, 2, · · · , l. Consider the following general
form of mathematical programming problems:
Minimize f(x)
subject to gi(x) ≤ 0 for i = 1, 2, . . . ,m,
hi(x) = 0 for i = 1, . . . , l,
x ∈ X,
(MP)
where f is called the objective function, and the remaining relations are called, the
inequality and equality constraints, respectively.
If the objective function, all the inequality and equality constraints are linear
functions, then (MP) is called a linear programming (LP). If the objective function
is quadratic while the constraints are all linear, then the optimization problem is
called a quadratic programming (QP) [3, 8, 25].
Given an optimization problem (MP), the Lagrangian function for this problem is
defined as







where the coefficients ui(i = 1, 2, . . . ,m) and vi(i = 1, . . . , l) are called the La-
grangian Multipliers.
Karush-Kuhn-Tucker (KKT) Necessary Conditions
Let x¯ be a feasible solution of (MP), and let I = {i : gi(x¯) = 0}. Suppose that f
and gi (i ∈ I) are differentiable at x¯, and each gi (i /∈ I) is continuous at x¯, and
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that each hi (i = 1, . . . , l) is continuously differentiable at x¯. Let ∇f(x¯), ∇gi(x¯)
and ∇hi(x¯) denote their gradients at x¯, respectively. Suppose that ∇gi(x¯)(i ∈ I)
and ∇hi(x¯), i = 1, 2, . . . , l, are linearly independent. If x¯ is an optimal solution of
(MP), then there exist unique scalars ui, i ∈ I and vi, i = 1, 2, . . . , l such that
∇f(x¯) +∑i∈I ui∇gi(x¯) +∑li=1 vi∇hi(x¯) = 0,
ui ≥ 0, ∀ i ∈ I.
(1.4)
The necessary condition (1.4) is called the Karush-Kuhn-Tucker Conditions or
KKT conditions for short. In addition to the above assumptions, if each gi (i /∈ I)
is also continuous differentiable at x¯, then the KKT conditions can be written in
the following equivalent form:
∇f(x¯) +∑i∈I ui∇gi(x¯) +∑li=1 vi∇hi(x¯) = 0,
uigi(x¯) = 0, ∀ i ∈ {1, 2, . . . ,m},
ui ≥ 0, ∀ i ∈ {1, 2, . . . ,m},
(1.5)
or in vector form as follows:
∇f(x¯) +∇g(x¯)Tu+∇h(x¯)Tv = 0,
uTg(x¯) = 0, u ≥ 0,
(1.6)
where g(x) = (g1(x), g2(x), . . . , gm(x)), h(x) = (h1(x), h2(x), . . . , hl(x)(x)), and
u ∈ Rm, v ∈ Rl. Moreover, if f is convex, all gi and hi are linear, then the KKT
conditions is a necessary and sufficient condition for a feasible point x¯ to be an
optimal solution of (MP).
Chapter 2
Molecular Classification Based on Gene
Expression Data
It is known that the microarray data could provide an auxiliary tool for cancer
diagnosis [15, 13, 4, 24]. In this chapter, we will mainly introduce the following
classification methods: Fisher’s linear discriminant, Bayesian classification, sup-
port vector machines, and boosting method.
2.1 Fisher’s Linear Discriminant
Fisher’s Linear Discriminant is a classical tool from statistical pattern recognition.
This method is to induce a decision rule on the instances by projecting training
instances to a carefully selected low-dimensional subspace. Suppose that we have
m tissue samples X1, X2, . . . , Xm, with m1 in class 1 (C1), m2 = m−m1 in class
2 (C2) and a total of n genes expression levels are measured in the microarray
experiment. Then, after hybridization and image analysis we obtain the following
12
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expression matrix:
T = [X1, X2, . . . , Xm] =

x11 x12 · · · x1m
x21 x22 · · · x2m
· · · · · · · · · · · ·
xn1 xn2 · · · xnm
 ,
where xij represents the level of expression of the ith gene in the jth sample.
Geometrically, Fisher’s Linear Discriminant Function [11] is to project the data
from an n dimensional space onto a straight line so that the projected samples are
separated as much as possible. In other words, this means that we would like to
find a vector w in Rn such that
yi = w
TXi, i = 1, 2, . . . ,m.
It is clear that each yi is the projection of the corresponding Xi onto a line in the
direction of w. Hence, our aim is to find the best direction w such that projections
are separated as much as possible. A measure on the separation between the






Xj, i = 1, 2.







TMi, i = 1, 2.
So, the distance between the projected sample means is
|M˜1 − M˜2| = |wT (M1 −M2)|,






(wTX − M˜i)2, i = 1, 2.
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Specifically speaking, Fisher′s LDF employs the linear function wTX to separate


















(X −M1)(X −M1)T +
∑
X∈C2
(X −M2)(X −M2)T .
In order to get the best separation between the two projected sets, it is known that
one can take w = S−1W (M1 −M2), which is shown to be a maximizer of J(w) (see,
[11]).
Thus, a classifier based on Fisher′s LDF is constructed in the following way:




wT (M1 +M2) =
1
2
(M1 −M2)TS−1W (M1 +M2),
then the classification rule for an unknown sample X0 is as follows:
assign X0 to C1 if (M1 −M2)TS−1W X0 ≥ Mˆ , and to C2 otherwise.
2.2 Support Vector Machines
In this section, we shall discuss the application of Support Vector Machines (SVMs)
in tumor classification. It is well known that SVMs is an effective tool to discover
informative patterns. The aim of support vector classification [8] is to devise a
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computationally efficient way of looking for a hyperplane in RN , such that all
samples on the one side of the hyperplane belong to class 1, and all the examples
on the other side belong to class 2. A hyperplane in RN has the form of wTx+b = 0,
this means that we should decide a vector w ∈ RN and a scalar b. In this section,
the labelled examples are denoted by (X1, l1), (X2, l2), . . . , (Xm, lm), where li = ±1,
is the label of Xi. If Xi is from class 1 then li = +1, otherwise li = −1.
Classification for a new sample x is performed by computing the sign of (wTx +
b). To find such a hyperplane that can separate samples (X1, l1), · · · , (Xm, lm)




i w + b) ≥ 1 i = 1, 2, . . . ,m.
The reason for using f(x) = ||w||2 as the objective function is as follows. We want
the hyperplane to separate the samples well, this can be done by maximizing the
margin. Since the geometric margin is equal to 1/||w||, we adopt the objective
function ||w||, and the constraints imposing that all samples in the training data
are classified correctly.
Such quadratic programings can be solved with its corresponding dual problem.
The primal Lagrangian function is








i w + b)− 1],
where α = (α1, . . . , αm) and αi ≥ 0 are the Lagrangian multipliers. Then, differ-























Then, substituting these two equations into the primal Lagrangian function, we
obtain










Consider the following quadratic programming
max w(α) =
∑m







i=1 liαi = 0, αi ≥ 0, i = 1, 2, . . . ,m.





is the desired weight vector and b∗ = [min{w∗TXi | li = 1} − max{w∗TXi | li =
−1}]/2. Furthermore, according to the Karush-Kuhn-Tucker (KKT) complemen-
tarity conditions (1.5), we have (w∗, b∗) and α∗ must satisfy
α∗i [li(w
∗TXi) + b∗ − 1] = 0, i = 1, 2, · · · ,m,
which implies that only for α∗i > 0, the corresponding tissues Xi are closest to
the hyperplane and determine the position of the hyperplane. Therefore, they are
called support vectors with respect to the hyperplane.
If the samples are not linearly separable, some kernel methods can be used. For
more details, see [8].
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2.3 Bayesian Classification
Recall the Bayes formula (see, [2, 11, 20]):
P (cj|X) = p(X|cj)P (cj)
p(X)
, (2.1)
where p(X|cj) is the data likelihood, i.e., the probability density function for vari-
able X conditioned on cj being true category of X. P (cj) is the prior probability
that an observation is of class cj. p(X) is the evidence and it can be viewed as





where X ∈ Rn is a feature vector. Here, we only consider the case of two categories,
that is, m = 2. It is noted that the above formular is true for any n classes, where
n ≥ 2. For the microarray data, the components of X represent the expression
levels of genes.
Given a particular X, we denote αi to be the action of deciding the true category is
class i, and define loss function λ(αi|cj) which describes the loss incurred for taking
action αi when the sample belongs to class j. Hence the expected loss associated





where P (cj|X) is the probability that the true class is class 1.
Generally, R(αi|X) is called the conditional risk. Under the Bayes decision rule,
we will choose the action αi so that the overall risk is as small as possible.
Let λij = λ(αi|cj), we write out the conditional risk given in (2.2) and obtain
R(α1|X) = λ11P (c1|X) + λ12P (c2|X), (2.3)
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and
R(α2|X) = λ21P (c1|X) + λ22P (c2|X). (2.4)
The classification rule is to decide c1 if R(α1|X) < R(α2|X) i.e
(λ21 − λ11)P (c1|X) > (λ12 − λ22)P (c2|X). (2.5)
By employing Bayes formula, we can rewrite (2.5) as:
(λ21 − λ11)p(X|c1)P (c1) > (λ12 − λ22)p(X|c2)P (c2) (2.6)
So, the structure of a Bayes classification is determined by the conditional densities
p(X|cj) as well as by the prior probabilities P (cj).
2.4 Boosting Method
The microarray data is not always linearly separable. If we construct a linear clas-
sifier to classify it, the accuracy of the classification is low. The goal of boosting is
to improve the accuracy of any given learning algorithm [11]. Under the assump-
tion that we have created a weak classifier with the accuracy on the training set
greater than that of random guess, boosting develops a component classifiers by
the procedure of training a weak component with the most informative training
data.
First, we randomly select a set of n1 < n samples from the full training set D, call
this set D1; and train the first weak classifier f1. Then we seek a second training
set D2, such that half of the samples in D2 should be correctly classified by f1,
half incorrectly classified by f1, and train a second component classifier f2 with
D2. Next we seek a third data set D3 from the remaining in D, which is not well
classified by f1,f2. In other words, we choose those samples that are classified
differently by f1,f2 and train the third component classified f3, the process is
iterated until a very low classification error can be achieved.
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There are a number of variations on basic boosting. In this section, we shall intro-
duce the most popular one–AdaBoosting. In AdaBoosting, each training sample
receives a weight that determines its probability of being selected for a training
set for an individual component classifier. In other words, we want to focus our
attention to those samples that are classified incorrectly by the current compo-
nent classifiers. Then we train the new classifier on the reweighted training set.
Examples are then reweighed again, and the process is repeated. The detailed
AdaBoosting procedure is shown in Box 2.1 ([4, 11]).
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Input:
• A microarray data set of m labelled samples D = {(X1, l1), ..., (Xm, lm)},
li ∈ {−1, 1} for two-class case.
• A weak classifier f0
• Iteration steps Kmax




, i = 1, · · · ,m.
For k = 1, 2, · · · , Kmax,
• Train weak classifier fk−1 using D with distribution, obtain fk

















where Zk is a normalizing constant to ensure that Wk+1(Xi) will sum to 1.
Output:





Box 2.1 AdaBoosting Procedure
Chapter 3
Gene Selection for Cancer Classification
3.1 Gene Selection Problem
Before the microarray experiments, people do not know exactly which genes are
related to the pathogenesis of the certain cancer. So, they try to use as many genes
as they can. But, many of these genes are irrelevant to the distinction between
tumor and normal tissues or different subtypes of the cancers. Taking such genes
into account during classification will have the following disadvantages. First, large
number of genes increase the dimensionality of the classification problem, the com-
putational complexity. Second, some genes have high mutual correlation. There
will be little gain if they are combined and used in the classification. Third, when
we design a classifier, we expect that it has high generalization capability. However,
for microarray data, thousands or even tens of thousands of genes versus tens of
tissue samples apparently reduce the generalization of the classifier. Thus, select-
ing subsets of genes will not only reduce noise but also have biological significance
to interpret the tumor development and may be useful for drug target discovery.
Moreover, another significance of gene selection is to develop an inexpensive diag-
nostic procedures for detecting diseases. The smaller of probes, the cheaper the
21
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microarrays. Therefore, it is important to recognize whether a small number of
genes can suffice for good classification.
Recently, many gene selection methods have been presented in publication, such as
Golub′s prediction strength method [15], Park’s nonparametric scoring algorithm
[22], Sun-Xiong’s mathematical programming approach [27]. In the rest of this
chapter, we will summarize these methods.
3.2 The Prediction Strength Method
This method was presented by Golub et al in 1999 and applied to distinguish ALL
from AML. The initial leukemia data set contains 6817 human genes hybridized
with RNA came from 27 ALL and 11 AML patients. The first issue of gene selection
is to explore whether there are genes who have different expression patterns in the
different classes. So a class distinction is defined by an idealized expression pattern
C = (c1, c2, · · · , cn),
where ci = 1 or 0 according to whether the i-th sample belongs to class 1 or class 2.
Then, all these genes were arranged by their correlations with the class distinction.
To measure “correlation” between a gene and the class distinction, Golub et al





where µ1(g), µ2(g), and σ1(g), σ2(g) denote the means and standard deviations of
the log of the expression levels of gene g for the tissues in class 1 and class 2,
respectively. If the expression level of gene g is (xA1, ..., xAm1 , xB1, ..., xBm2), then


























where xAi is the expression value of gene g in the ith tissue of class 1, and xBi is
the expression value of gene g in the ith tissue of class 2. The larger the value
of |p(g, c)|, the stronger correlation between the gene expression and the class
distinction. And, if p(g, C) > 0 (or p(g, C) < 0), it indicates that g is more highly
expressed in class 1 (or class 2). If n informative genes will be selected, then these
n selected genes will consist of the n/2 genes closest to the class distinction high
in class 1, that is, p(g, C) as large as possible; and n/2 genes closest to the class
distinction high in class 2, that is, −p(g, C) as large as possible. In [15], n is set
to 50.
Based on these 50 selected genes, a very special and feasible classification procedure
was proposed. We call itWeighted Voting Method. Given a testing sample X, each
informative gene casts a weighted vote for one of the classes. The vote is not only
on the basis of the expression level of this gene in the testing sample but also
related to the correlation value with the class distinction.
The vote of gene g for the new sample X is defined as
Vg = p(g, C)
(




where Xg denotes the expression level (has been normalized) of gene g in the new
sample X. A positive value of Vg indicates a vote for class 1 and a negative value
of Vg indicates a vote for class 2. The sum of all the positive votes, denoted by V1,
is the total vote for class 1, while the sum of the absolute values of the negative
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votes, denoted by V2, forms the total vote for class 2. However, after obtaining the
total votes V1 and V2 for class 1 and class 2, it does not mean the bigger one is the
true winner since the relative margin of victory must be considered, which is said





where Vwin and Vlose are the total votes for the winning and losing classes, respec-
tively. The new sample X will be assigned to the winning class if PS exceeds
a predetermined threshold. Otherwise, it is considered uncertainty. In [15], the
threshold is set to be 0.3.
3.3 Pre-filter Method
Pre-filter method is often used to enhance the efficiency or the accuracy of a
method. For example, in [27], Sun et al applied the approach of preliminary se-
lection to reduce the number of genes before they perform their gene selection
procedure. By doing so, they were able to make the gene selection model within a
manageable size hence improve the efficiency. In this section, we’d like to introduce
a pre-filter method proposed by Jaeger et al [19]. The purpose of this pre-filter
method is to reduce the correlation among the selected genes.
Just like Golub et al′s method discussed in Section 3.2, conventional gene selec-
tion proceeds by ranking genes according to a test-statistic and choosing the top
k genes [16]. A problem aroused from this method is that many selected genes
are highly correlated. It may result in additional computational burden and leads
to misclassifications. Furthermore, if there is a limit on the number of genes for
selection, we might omit some informative genes. So, in [19], a pre-filter approach
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was presented. The idea of this method is to find similar genes and group them,
then select the informative genes from these groups to avoid redundancy.
Gene Adenoma Normal t-test
Names 1 2 3 4 1 2 3 4 P-value
M18000 705.41 1227.27 959.35 951.56 359.83 711.08 485.33 431.19 0.014
X62691 387.91 577.57 578.45 546.54 227.26 436.65 306.94 239.33 0.016
M82962 91.85 16.27 12.61 61.62 187.44 76.90 181.38 186.53 0.017
U37426 0.47 7.05 6.30 3.40 -3.88 1.58 -2.99 -2.91 0.018
HG2564 2.33 0.54 1.58 3.82 -2.91 -2.11 1.00 -2.91 0.019
Z50853 35.43 26.03 51.49 41.22 27.68 15.80 12.46 15.99 0.022
M32373 -48.02 -28.20 -64.62 -56.95 -15.05 -16.86 -7.97 -34.88 0.022
Table 3.1: Expression values for 7 selected genes of Adenoma and normal tissues, sorted
by P -value [19].
For example, Table 3.1 shows the expression values for 7 selected genes of Adenoma
and normal tissues sorted in the increasing order by P - value. From the table, we
find that for gene M18000 and X62691, the expression values are generally higher
in Adenoma than in Normals with the exception of Adenoma 1 and Normal 2.
Both of them have a very low p-value, so they could be selected by conventional
methods. However, we cannot obtain more information with both of them rather
than either one alone as they show the same overall pattern.
Looking at the correlation values in Table 3.2, we see that they have a very high
correlation value. In general, we think that genes with high correlation can have
a biological explanation. For example, perhaps they belong to the same pathway
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M18000 X62691 M82962 U37426 HG2564 Z50853 M32373
M18000 1.000
X62691 0.961 1.000
M82962 -0.944 -0.971 1.000
U37426 0.973 0.975 -0.983 1.000
HG2564 0.592 0.653 -0.553 0.529 1.000
Z50853 0.514 0.616 -0.633 0.597 0.614 1.000
M32373 -0.509 -0.590 0.602 -0.580 -0.619 -0.874 1.000
Table 3.2: Correlation between Adenoma genes from Table 3.1 [19].
or they are coming from the same chromosome. If more genes from one pathway
are selected for classification, computational complexity may be increased and the
result can be skewed. Thus, typically, we prefer to use more uncorrelated genes
in order to increase the classification performance. Therefore, in [19], the authors
gave an approach which prefilters the gene set and drops correlated genes first,
then apply a typical method to the remaining genes, namely, choosing high-ranking
genes.
In prefilter process, all genes are clustered by the fuzzy clustering method, and each
cluster has its own quality index, which is a measurement of how scattered a cluster
is. In fuzzy clustering method, each gene is assigned a membership probability for a
cluster. Hence, the cluster quality is defined by the average membership probability
of its elements.
In gene selecting process, in order to avoid loosing all the information of a pathway,
a principle that each cluster contributes at least one gene would be followed.
3.4 Gene Selection by Mathematical Programming 27
3.4 Gene Selection by Mathematical Program-
ming
Feature selection via mathematical programming has been intensively studied re-
cently [5, 6, 27]. In fact, feature reduction is an indirect consequence of the support
vector machine approach when an appropriate norm is chosen. It is known that
for a given microarray data set containing two kinds of tissue sets C1 and C2, we
would like to discriminate between them by a separating plane:
wTX = b. (3.4)
If the two sets are linearly separable, we shall determine w and b so that the two
kinds of tissue sets are contained in the two different half spaces, which are defined
by the separating plane, that is
wTXi > b, ∀ Xi ∈ C1, (3.5)
and
wTXi < b, ∀ Xi ∈ C2. (3.6)
If the samples are not completely linearly separable, this is almost always the case
in many real-world applications, we attempt to minimize the violations of (3.5)
and (3.6). That is to minimize the misclassification errors. In [5], the objective
function is to minimize some norm of the average violations while in [27], a goal
programming model is constructed by minimizing the sum of violations.
In order to avoid the trivial solution where w = 0 and b = 0, a method of normal-
ization is used. Hence, we would like w and b to satisfy the following conditions:
wTXi ≥ b+ 1, ∀ Xi ∈ C1, (3.7)
and
wTXi ≤ b− 1, ∀ Xi ∈ C2. (3.8)
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Since our tissue sets C1 and C2 are not always linearly separable, we try to minimize











(wTXi − b+ 1)
 , (3.9)
where I1 and I2 denote Class 1 and Class 2 tissue index sets, respectively.






s. t. −wTXi + b+ 1 ≤ αi, i ∈ I1,
wTXi − b+ 1 ≤ βi, i ∈ I2,
αi ≥ 0, βi ≥ 0, i ∈ I1 ∪ I2.
(3.10)
If no gene selection is involved, then problem (3.10) would be a complete model
to find a separating plane P that approximately satisfies (3.7) and (3.8). Actually,
each positive value αi determines the distance between a Class 1 tissue sample
lying on the wrong side of the bounding plane
wTX = b+ 1 for C1,
i.e., Xi satisfying
wTXi < b+ 1,
and the bounding plane
wTX = b+ 1.
Similarly, for C2 and
wTX = b− 1.
Thus, linear programming (3.10) minimizes the sum of the distances of misclassified
points to the bounding planes.
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Next step, we would like to consider the gene selection problem in (3.10). A gene
gj is used in the classification model (3.10) if wj 6= 0. So, in order to limit the
number of genes in the classifier, an extra item is added to the objective function






i∈I2 βi) + λ
∑
j∈J yj
s. t. −wTXi + b+ 1 ≤ αi, i ∈ I1,
wTXi − b+ 1 ≤ βi, i ∈ I2,
αi ≥ 0, βi ≥ 0, i ∈ I1 ∪ I2,
yj = 0 or 1, j ∈ J,
wj −Myj ≤ 0, j ∈ J,
−wj −Myj ≤ 0, j ∈ J.
(3.11)
Where, λ ∈ [0, 1) is a constant number and M is a positive number which is large
enough. J denotes the genes index set. If wj 6= 0, the last three constraints in
(3.11) ensure yj = 1. And, if wj = 0, then yj = 0.
There are different approaches to deal with the item
∑
j∈J yj. In [5], in order to
overcome the discontinuity of λ
∑
j∈J yj such that some continuous method can be







(1− e−ν|wj |), ν > 0.
In [27], without considering the weighted parameter λ, the item
∑
j∈J yj is treated
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as another objective function. Thus, a multiple objective mathematical program-









s. t. −wTXi + b+ 1 ≤ αi, i ∈ I1,
wTXi − b+ 1 ≤ βi, i ∈ I2,
αi ≥ 0, βi ≥ 0, i ∈ I1 ∪ I2
yj = 0 or 1, j ∈ J,
wj −Myj ≤ 0, j ∈ J,
−wj −Myj ≤ 0, j ∈ J.
(3.12)
A gene gj is selected in the classification model only if wj 6= 0 in the solution of
the gene selection model (3.12). Let J1 denote the set of genes in the classification
model, i.e.
J1 = {j ∈ J | wj 6= 0}
After the w′js are estimated, we can get the following classification function to





X is classified as a normal tissue if Y > 0, as a tumor tissue if Y < 0, and not
classified if Y = 0.
The gene selection model (3.12) is a multiple objective mathematical programming
(MP) model. If there are large number of variables involved, this multiple objective
MP problem is usually not easy to solve. In [29], Steuer presented a ²-constraint
method to solve such problem. In that method, an integer value ² was assigned to
the second objective function
∑
j∈J yj and convert it to a constraint, i.e.∑
j∈J
yj ≤ ² (3.13)
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s. t. −wTXi + b+ 1 ≤ αi, i ∈ I1,
wTXi − b+ 1 ≤ βi, i ∈ I2,
αi ≥ 0, βi ≥ 0, i ∈ I1 ∪ I2
yj = 0 or 1, j ∈ J,
wj −Myj ≤ 0, j ∈ J,
−wj −Myj ≤ 0, j ∈ J,∑
j∈J yj ≤ ².
(3.14)
By doing so, the number of genes in the classification model is limited to ². There
are many softwares to solve the above MP problem, for example, CPlex is one of
high-performance optimization softwares.
3.5 A Nonparametric Scoring Method
In order to select informative genes, which have different expression levels in the
two classes, from microarray data, some researchers applied various methods of
feature ranking [13, 15, 23]. They evaluated how well a single gene contributes to
the classification with various correlation coefficients. In [15], the coefficient was
defined as (3.1), whereas in [13], the absolute value of p(g, C) defined in (3.1) was







It is noted that all the above ranking criteria employ some statistics.
In this section, we would like to introduce a quite different but more systematic
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and robust nonparametric scoring method given by Park et al in [22]. It is fast and
easy to understand. We assume that there are total of m tissues, with m1 tissues
in class 1 and m2 tissues in class 2. And we assign a score to each gene as follows.
First, for each gene (represented by a vector) we assign 0
′
s to the first m1 elements
in class 1 and 1
′
s to the last m2 elements in class 2. Then, we sort the expression










s, which indicates the class membership and an ordered expression levels.
The following example demonstrates this process. Suppose we havem = 6,m1 = 3,
and m2 = 3 in this example.
Tissues : 1 2 3 4 5 6
Expression values of gene g : 385 206 36 84 59 195
Classes : 0 0 0 1 1 1
Aftersorting :
Expression values of gene g : 36 59 84 195 206 385
Classes : 0 1 1 1 0 0
The more correspondence between the expression levels and the class membership,




s are grouped together. The ideal informative genes (if
exist) should have a sequence of all 0
′
s followed by all 1
′
s, or vice versa, after
sorting.




s. It is defined as
the smallest number of swaps of consecutive digits necessary to arrive at a perfect
splitting, with all 0
′
s on the left and all 1
′
s on the right.
In the above example, the gene g has a score of 6 as shown below.
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Score : data : positions swapped
0 1 1 1 0 0
+1 0 1 1 0 1 0 4 and 5
+1 0 1 0 1 1 0 3 and 4
+1 0 0 1 1 1 0 2 and 3
+1 0 0 1 1 0 1 5 and 6
+1 0 0 1 0 1 1 4 and 5
+1 0 0 0 1 1 1 3 and 4
Hence, both a low and a high score indicate an informative gene which expresses
differently in two kinds of tissues. The maximum score is m1m2, which happens
when the digits are completely in reverse. In this case, m2 digits need to be moved
m1 spaces away, for the total of m1m2 swaps.
In order to determine how many genes should be selected for further classification.
Park et al [22] computed P -value s by comparing the distribution from the original
data to the set of distributions obtained from the randomly column-permuted data.
The reason for choosing the random permutation of the entire columns instead of
generating random sequences of m1 0
′
s and m2 1
′
s is that the gene expressions
are correlated among genes but not independent. With this attempt, the authors
could keep gene to gene correlation fixed. At last, by considering the appropriate
P -value, they think that 5% of genes seemed to be a reasonable number for further
analysis. And, what convinced us is that all 50 genes selected by Golub et al are
included in these top 5% genes.
Chapter 4
A New Method for Gene Selection
In this chapter, we will propose a new method for the gene selection problem.
Then, we apply this method to colon cancer data and ALL-AML data. The results
and discussion are presented in Sections 4.2 and 4.3, respectively.
4.1 Gene Selection Method
There are many diverse purposes of gene selection. In this thesis, we are primarily
concerned with gene selection for tissue classification purposes, we hence are very
interested to those genes which can express very differently in different classes of
tissues. In microarray data, the expression level of a gene is characterized by a
vector whose components represent the expression values of this gene in different
samples. The proposed method is motivated by what follows. We suppose that, for
each gene, its average expression, to some extent, represents a general the gene’s
intrinsic expression level. We then need to find those components which indeed
deviate from the above average value. Hence, we attempt to find a novel, effective
and simpler method to identify these genes.
It is easy to see that, for any two 0-1 vectors (i.e., their entries are either 0 or 1),
34
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u and v from the same dimensional space, the inner product of u and v actually
counts the number of 1’s that lie in the same locations. This property can be
used to study the relationship of 0-1 vectors. We hence apply a similar idea to
our method of gene selection, where we reduce the original expression vectors to
vectors whose entries are +1, −1, or 0, using the following method.
Throughout this chapter, for convenience in description, for any gene g under




x11 x12 · · · x1m
x21 x22 · · · x2m
· · · · · · · · · · · ·
xn1 xn2 · · · xnm
 .
Here X contains m1 Class 1 tissues, which are arranged in the first m1 columns in
X and m2 = m−m1 Class 2 tissues in the last m2 columns in X. The ith row of
matrixX represents the expression vector of gene gi denoted by gi = (xi1, · · · , xim),












If the absolute value of αij is greater than a given positive threshold, we then regard
the gene gi has different expression in tissue j comparing with the average value.
Given a scale α0, according to whether αij ≥ α0, or αij ≤ −α0, or −α0 < αij < α0,
we transform the value of xij to +1, or -1, or 0, respectively, and denote the
corresponding reduced expression vector by g′i. Thus, if gene gi indeed expresses
differently in two classes of tissues, then there should be many +1′s in the left (or
right) half of g′i and many −1′s on the right (or left) half. Subsequently, we define
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Input:
• A microarray data set matrix X = (xij)n×m
• α0, g0 = (1, 1, · · · , 1,−1,−1, · · · ,−1)











• If αij ≥ α0, set xij = 1; if αij ≤ −α0, set xij = −1;
Otherwise, set xij = 0.
• Calculate βi = |〈gi, g0〉|, i = 1, 2, . . . , n
Output:
i’s corresponding to βi ranked in decrement, i = 1, 2, . . . , n
Table 4.1: Algorithm for Gene Seclection
an idealized gene whose expression vector is
g0 = (1, 1, · · · , 1,−1, · · · ,−1).
This ideal gene g0 with expressions completely match the two given classes. Our
next work is how to select those genes who have similar expression pattern with
this ideal gene. To measure the similarity, we resort to the inner product 〈g′i, g0〉 as
mentioned above. Then the absolute value of 〈g′i, g0〉 will indicate the coincidence




In this section, we apply our method proposed in last section to colon cancer data
set analyzed by Alon [1] and ALL-AML data set provided by Golub et al [15]. The
colon data set consists of expression profiles of n = 2000 genes in m1 = 22 normal
and m2 = 40 tumor tissues. We can see that there are much more tumor examples
than normal examples in this data set. In order to avoid the effect produced by
the different sizes of tumor and cancer samples under consideration, we choose
the same size sub-samples in our practical program, say 22 normal vs. 22 cancer
tissues. For ALL-AML data set where n = 6871, m1 = 27 and m2 = 11, we use
the sub-samples of 11 ALL and 11 AML.
We wrote C programs to implement our algorithm on the sub-samples of these two
original data sets and run them on a PC with Windows XP systems. The detailed
C codes are attached in Appendix.
After obtaining the informative genes, Fisher′s LDF and SVMs are used to classify
the tissues with the genes selected by our algorithm. The detailed Fisher′s LDF
program is attached in Appendix. For SVMs algorithm, we use Gist Support
Vector Machine Web Interface([14]). In classifying process, we apply the “Leave-
One-Out” approach to validate the classification. In this approach, one tissue is
left out in turn and the other m − 1 tissues are used to set up the classifier with
Fisher′s LDF and SVMs. Then, with this classifier, we classify the tissue that is
left out. This process is repeated m times, once for each tissue. Then, we count
the number of the misclassified tissues in the whole process.
In the proposed method, the idea of choosing scale α0, which has been used to
reduce gi to g
′
i, is followed from our numerical experiments. In the implementation
of our algorithm in colon cancer data and ALL/AML data, after trying some scales,
we found that α0 greater than 0.5 does not work with. While if α0 is too small, the
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genes with no distinct expressions in two classes would be possibly selected, which
violates the intention of gene selection. When setting α0 = 0.2, 0.25, 0.3, 0.35,
the results obtained have shown no much distinction under these cases. In this
thesis, we choose one parameter, i.e., α0 = 0.25, among them for the purpose of
implementation, under which case the performance appears slightly better than
the other situations. We also think that the choice of α0 can vary with different
kinds of microarray data under test.
For colon data, the first subset of 4 genes was selected with the α0 = 0.25 under
consideration the subsample of 22 normal samples and the first 22 tumor samples.
Then with different choices of the subsamples, we obtained different subsets of
genes. For each selected subset of genes, we report the number of misclassified
cases in each group and overall classification rate obtained with Fisher′s LDF and
SVMs in Table 4.2 and Table 4.3. A number in a column under “Training” is the
number of misclassified cases out of the number of examples in the training set.
And, the number in the column under “Testing” is the total number of misclassified
cases for Leave-One-Out approach. Table 4.2 shows that using four-gene subsets
selected by our algorithm can yield at least 83.9% accuracy of classification. In
Table 4.3, we see that with the four-gene subsets of ALL-AML data the accuracy
can be over 93% even 100% in some cases.
4.3 Discussion
In this chapter, we analyzed the gene expression data of colon cancer and acute
leukemia with our proposed method. We only discuss the subsets of genes con-
taining four genes because it was suggested in [30] that the expression information
from three or four genes is near optimal for tumor classification in these two data
sets. From the results showed in Table 4.2, we can see that our results can provide
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Fisher’s LDF SVMs
Genes Selected Training Testing Training Testing































Average Accuracy 87.1% 86.03% 87.1% 87.1%
Table 4.2: Number of misclassified cases and accuracy of classification for different
subsets of genes selected for the colon cancer data set.
further evidence that the four-gene subset indeed achieved high classification rates.
For colon data, four-gene subsets selected by our algorithm can yield more than
87% accuracy of classification. In Table 4.3, we can see that with the four-gene
subsets of ALL-AML data the accuracy can be over 95% even 100% in some cases.
In [27], Sun and Xiong provided some results of classification for these two microar-
ray data sets, using Fisher’s LDF with genes selected by Mathematics Program-
ming (MP) as shown in Tables 4.4 and 4.5. By comparing our results with those of
them, we can see that for the ALL-AML data the average accuracy of classification
with genes selected by our method apprently exceeds that of method of Sun and
Xiong. For the colon cancer data, the average accuracies of their method and ours
are very close. In general, we can see that our proposed method is feasible and
seems to be superior to the MP method introduced by Sun and Xiong [27] in gene
selection.
On the other hand, we learned that the optimal or near optimal set of genes may
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Fisher’s LDF SVMs
Genes Selected Training Testing Training Testing































Average Accuracy 100% 96.5% 95.6% 93.7%
Table 4.3: Number of misclassified cases and accuracy of classification for different
subsets of genes selected for the ALL-AML cancer data set.
not be unique. There may exist a number of sets of genes whose accuracy of
classification is quite close. For example, three subsets of genes showed in Table
4.3 all can provide an accuracy of classification greater than 94% for training data,
and 92% for Leave-one-out approach.
There is no single best procedure for selecting an optimal subset of genes for tumor
classification. According to the overall performance showed in Tables 4.2 and 4.3,
the method introduced here is useful and promising. It is simple and efficient,
because it uses the reduced expression values to study the difference expression
between two samples rather than actual expression levels. It seems that it would
lose some information. But this doesn’t matter since there is a long sequence of
steps in the laboratory as well as in the image analysis before a single number is
produced for an expression level, and there are many potential sources of error. So
the expression levels are often unreliable.
This method can be an alternative or a complement to other methods because
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Training Testing






















Average Accuracy 87.5% 85.9%
Table 4.4: Gene Selection with MP and Classification with Fisher’s LDF for the Colon
Cancer Data [27]
each method may have different performance under different conditions. However,
it needs more investigation and improvement in the future. For example, how to
select a suitable α0, and how many genes should be used for tissue classification. So
the further studies are needed to give out some statistical analyses about choosing a



































Average Accuracy 91.3% 88.9%





[1] U. Alon, N. Barkai, D. A. Notterman, K. Gisk, S. Ybrarra, D. Mack, and A.
J. Levine. Broad Patterns of Gene Expression Revealed by Clustering Analysis
of Tumor and Normal Colon Tissues Probed by Oligonucleotide Arrays. Proc.
Natl. Acad. Sci. USA, 96: 6745-6750, 1999.
[2] P. Baldi and A. D. Long. A Bayesian Framework for the Analysis of Microarray
Expression Data: Regularized t-test and Statistical Inferences of Gene Changes.
Bioinformatics, 17: 509-519, 2001.
[3] M. S. Bazaraa, H. D. Sherali, and C. M. Shetty. Nonlinear Programming: The-
ory and Algorithms, 2nd Edition, John Wiley & Sons, 1993.
[4] A. Ben-Dor, L. Bruhn, N. Friedman, I. Nachman, M. Schummer, and Z.
Yakhini. Tissue Classification with Gene Expression Profiles. J. Comput. Biol.,
7: 559-584, 2000.
[5] P. S. Bradley, O. L. Mangasarian, and W. N. Street. Feature Selection via
Mathematical Programming. INFORMS Journal on Computing, 10: 209-217,
1998.
[6] P. S. Bradley, O. L. Mangasarian. Feature Selection via Concave Minimiza-
tion and Support Vector Machines. Proceedings of International Conference on
Machine Learning (ICML), 82-90, 1998.
[7] P. Clote and R. Backofen. Computational Molecular Biology: An Introduction,
John Wiley & Sons Inc., 2000.
[8] N. Cristianini and J. Shawe-Taylor. An Introduction to Support Vector Ma-
chines and other Kernel-Based Learning Methods, Cambridge University Press,
2000.
Bibliography 45
[9] J. M. Deutsch. Evolutionary Algorithms for Finding Optimal Gene Sets in
Microarray Prediction. Bioinformatics, 19: 45-52, 2003.
[10] J. L. Devore. Probability and Statistics for Engineering and the Sciences,
Brooks/Cole Publishing, 1995.
[11] R. O. Duda and P. E. Hart. Pattern Classification, John Wiley & Sons Inc,
1973.
[12] D. J. Duggan, M. Bittner, Y. Chen, P. Meltzer, and J. M. Trent. Expres-
sion Profiling Using cDNA Microarrays. Nature Genetics Supplement, 21: 10-14,
1999.
[13] T. S. Furey, N. Duffy, N. Cristianini, D. Bednarski, M. Schummer, and D.
Haussler. Support Vector Machine Classification and Validation of Cancer Tis-
sue Samples Using Microarray Expression Data. Bioinformatics, 16: 906-914,
2000.
[14] Gist Support Vector Machine Web Interface, http://svm.sdsc.edu/cgi-
bin/nph-SVMsubmit.cgi.
[15] T. R. Golub, D. K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J. P.
Mesirov, H. Coller, M. L. Loh, J. R. Downing, M. A. Caligiuri, C. D. Bloomfield,
E. S. Lander. Molecular Classification of Cancer: Class Discovery and Class
Prediction by Gene Expression Monitoring. Science, 286: 531-537, 1999.
[16] I. Guyon, J. Weston, S. Barnhill, and V. Vapnik. Gene Selection for Cancer
Classification Using Support Vector Machines. Machine Learning, 46: 389-422,
2002.
[17] T. Hellem B∅, and I. Jonassen. New Feature Subset Selection Procedures for
Classification of Expression Profiles. Genome Biology, 3: 1-17, 2002.
Bibliography 46
[18] K. R. Hess, W. Zhang, K. A. Baggerly, D. N. Stivers, and K. R. Coombes.
Microarrays: Handling the Deluge of Data and Extracting Reliable Information.
Trends in Biotechnology, 19: 463-468, 2001.
[19] J. Jaeger, R. Sengupta, and W. L. Ruzzo. Improved Gene Selection for Clas-
sification of Microarrays. Proceedings of Pacific Symposium on Biocomputing, 8:
53-64, 2003.
[20] K. E. Lee, N. Sha, E. R. Dougherty, M. Vannucci, and B. K. Mallick. Gene
Selection: A Bayesian Variable Selection Approach. Bioinformatics, 19: 90-97,
2003.
[21] R. Nadon, and J. Shoemaker. Statistical Issues with Microarrays: Processing
and Analysis. Trends in Genetics, 18: 265-271, 2002.
[22] P. J. Park, M. Pagano, and M. Bonetti,. A Nonparametric Scoring Algorithm
for Identifying Informative Genes from Microarray Data. Proceedings of Pacific
Symposium on Biocomputing, 52-63, 2001.
[23] P. Pavlidis, J. Weston, J. Cai, and W. N. Grundy. Gene Functional Clas-
sification from Heterogeneous Data. Proceedings of Research in Computational
Molecular Biology (RECOMB) Conference, 249-255, 2001.
[24] S. Ramaswamy, P. Tamayo, R. Rifkin, S. Mukherjee, C.-H. Yeang, M. Angelo,
C. Ladd, M. Reich, E. Latulippe, J. P. Mesirov, T. Poggio, W. Gerald, M. Loda,
E. S. Lander, and T. R. Golub. Multiclass Cancer Diagnosis Using Tumor Gene
Expression Signatures. Proc. Nalt. Acad. Sci., 98: 15149-15154, 2001.
[25] R. T. Rockafellar, Convex Analysis, Princeton, New Jersey, 1970.
Bibliography 47
[26] C. Sugnet, E. Rice, T. Clark. Rational Selection of Oligonucleotide Probes for
Microarray Construction. Working paper, Baskin School of Engineering, Univer-
sity of California, Santa Cruz. December 1, 1999.
[27] M. Sun, and M. Xiong. A Mathematical Programming Approach for Gene
Selection and Tissue Classification. Bioinformatics, 19: 1243-1251, 2003.
[28] Primer on Molecular Genetics, U.S. Department of Energy, Office of Health
and Environmental Research & Human Genome Management Information Sys-
tem, Oak Ridge National Laboratory, June 1992.
[29] R. E. Steuer, Multiple Criteria Optimization: Theory, Computation, and Ap-
plication. Wiley, New York, 1986.
[30] M. Xiong, W. Li, J. Zhao, L. Jin, and E. Boerwinkle. Feature (Gene) Se-
lection in Gene Expression-Based Tumor Classification. Molecular Genetics and
Metabolism, 73: 239-247, 2001.
[31] M. Xiong, X. Fang, and J. Zhao. Biomarker Identification by Feature Wrap-
pers. Genome Research, 11: 1878-1887, 2001.
[32] Y. H. Yang, and T. Speed. Design Issues for cDNA Microarray Experiments.
Nature Reviews Genetics, 3: 579-588, 2002.
Appendix A
C Program Source Codes for Gene
Selection
/******************************
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void main(void){
int k, i, j, l, row, col, num, count;
int selected_gene_name[6], Idealized_gene[62],Temp_Tissue[62];
FILE *fptr, *temp, *fp;
char tmpbuf[100], fNameStr[100], buff[100], Tissue[70][3];
float Normal_mean[2000], Normal_deviation[2000], M[2000][62];
float New_M[2000][62], SelectedGene_Matrix[4][62];
float Transpose_GeneMatrix[62][4];
double Gene[2000], Mean, Sum;
/******************************************/
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fclose(fptr);
/******************************

























{ for(col=0; col<62; col++)















// Re-save the data matrix as a txt file
if((temp=fopen("matrix.txt", "w"))==NULL){
printf("Cannot open the file. \n");
exit(1);}
for(row=0; row< 2000; row++)
{ for(k=0; k<62; k++)
{ fprintf(temp, "%f", M[row][k]);




// Read the tissue raw data file to be a string
fp=fopen(Quesfile2, "r");
if (fptr==NULL) {




















// Save as a tissue txt file
if((temp=fopen("tissuse.txt", "w"))==NULL){
printf("Cannot open the file. \n");
exit(1);}
for(row=0; row< 62; row++)
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printf("Cannot open the file. \n");
exit(1);}




Re-order the normal and cancer tissues,































printf("Cannot open the file. \n");
exit(1);}
for(row=0; row<2000; row++)
{ for(col=0; col<62; col++)
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{ if(-EPSILON <(New_M[row][col] - Mean)/Mean <EPSILON)
{ M[row][col]=0; }





for(row=0; row< 2000; row++)
{ for(col=44; col< 62; col++)
M[row][col]=0; }




{ Sum= M[row][col]*Idealized_gene[col] +Sum;}
Gene[row]=Sum; }
// Save as gene.txt
if((temp=fopen("gene.txt", "w"))==NULL){
printf("Cannot open the file. \n");
exit(1);}
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for(row=0; row< 2000; row++)
fprintf(temp, "%f\n", Gene[row]);
fclose(temp);
// Select the ideal genes from re-ordered matrix New_M
count=0;
for(row=0; row<2000; row++)
{ if(Gene[row]>=DELTA || Gene[row]<=-DELTA)











fprintf(temp, "Selected gene numbers with epsilon=EPSILON
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fclose(temp);
/*********************************************************/
for(row=0; row< 62; row++)

























{ fprintf(temp, "%s", "Cancer_");


























printf("Cannot open the file. \n");
exit(1);


















{ fprintf(temp, "%s", "Cancer_");
fprintf(temp, "%d\t", row+1);
for(col=0; col<count; col++)





printf("Cannot open the file. \n");
exit(1);}












C Program Source Codes for
Classification Using FLD
/*************************************************
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{double **a, d, **c;
int n, *indx, sign, i, j, k, row, col, l;





























/* To get the matrix M */
k=0, j=0, row=0;
for(row=0; row<COUNT; row++)












































/* Memory Allocation */












































































printf("(%f %f) ", Test_Value, Mid_Point);}


































































fprintf(stderr,"Numerical Recipes run-time error...\n");
fprintf(stderr,"%s\n",error_text);
fprintf(stderr,"...now exiting to system...\n");
exit(1);




























m=(double **) malloc((unsigned) (nrh-nrl+1)*sizeof(double*));
if (!m) nrerror("allocation failure 1 in matrix()");
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m -= nrl;
for(i=nrl;i<=nrh;i++) {
m[i]=(double *) malloc((unsigned) (nch-ncl+1)*sizeof(double));









m=(double **) malloc((unsigned) (nrh-nrl+1)*sizeof(double*));
if (!m) nrerror("allocation failure 1 in dmatrix()");
m -= nrl;
for(i=nrl;i<=nrh;i++) {
m[i]=(double *) malloc((unsigned) (nch-ncl+1)*sizeof(double));









if (!m) nrerror("allocation failure 1 in imatrix()");
m -= nrl;
for(i=nrl;i<=nrh;i++) {
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m[i]=(int *)malloc((unsigned) (nch-ncl+1)*sizeof(int));










m=(double **) malloc((unsigned) (oldrh-oldrl+1)*sizeof(double*));




























































m = (double **) malloc((unsigned) (nrow)*sizeof(double*));
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#define TINY 1.0e-20;
void ludcmp(a, n, indx, d)
int n, *indx;
double **a, *d;
{ int i, imax, j, k;








if ((temp=fabs(a[i][j])) > big) big=temp;


































if (a[j][j] == 0.0) a[j][j]=TINY;























for (j=ii;j<=i-1;j++) sum -= a[i][j]*b[j];
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